Rigel Pharmaceuticals, Inc. (RIGL)
35.46
-1.18
(-3.22%)
USD |
NASDAQ |
Feb 20, 16:00
35.45
-0.01
(-0.03%)
After-Hours: 20:00
Rigel Pharmaceuticals SG&A Expense (Quarterly) : 28.94M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Nektar Therapeutics | 16.07M |
| Eli Lilly & Co. | 3.132B |
| Ironwood Pharmaceuticals, Inc. | 21.91M |
| BioMarin Pharmaceutical, Inc. | 268.40M |
| Catalyst Pharmaceuticals, Inc. | 42.21M |